Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Centre Leon Berard: Clinical Trials & FDA Approval Profile

Centre Leon Berard (Global / Institutional) sponsors 42 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 21 active protocols (12 recruiting now), 9 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)16.7%
Median Closed Enrollment vs National (145 pts)40 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Centre Leon Berard
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)42
Active Pipeline (Recruiting Now)21 (12)
Completed vs Stopped Early9 / 7 (16.7%)
Median Closed Actual Enrollment40 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Centre Leon Berard
Hospital Research SiteLocationShared Protocols
Centre Léon BérardLyon30
Institut Gustave RoussyVillejuif17
Centre Antoine-LacassagneNice15

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Centre Leon Berard
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06692556Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas SpinocellularPhase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Centre Leon Berard Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI